Mounjaro 15 mg (Tirzepatide) KwikPen – Weekly Injection for Weight Management (4 doses x 15 mg)
Mounjaro 15 mg (Tirzepatide) is an advanced dual-action peptide designed to support weight management and metabolic balance. Acting on both GIP and GLP-1 receptors, it helps regulate appetite, improve insulin sensitivity, and support stable blood sugar levels.
The convenient KwikPen format allows for precise and easy subcutaneous administration once per week.
Key Benefits of Mounjaro 15 mg
- Supports significant weight reduction
- Helps control blood sugar levels
- Reduces appetite and food cravings
- Supports metabolic function
- May improve cardiovascular markers
- Easy once-weekly injection
Indications
- Type 2 diabetes support
- Overweight and obesity
- Metabolic imbalance
Contraindications
- Age under 18
- Hypersensitivity to components
- Severe gastrointestinal disorders
- History of pancreatitis
- Pregnancy and breastfeeding
- Thyroid conditions (including family history of medullary thyroid cancer)
Dosage & Administration
Administer once weekly via subcutaneous injection.
Injection sites:
- Abdomen
- Thigh
- Upper arm
Rotate injection sites regularly. Dosage should be adjusted individually under professional supervision.
Mounjaro 15 mg – Maximum Strength
The 15 mg dosage represents the highest strength in the Mounjaro range and is typically used after gradual dose escalation. It provides enhanced support for appetite control and metabolic processes.
The KwikPen ensures accurate dosing and user-friendly application, making it suitable for long-term use.
Reviews
There are no reviews yet.